Current position

Renaissance Technologies LLC’s Globus Med Inc (GMED) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Renaissance Technologies LLCVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ3 2018Earliest verified positive filing snapshot
Latest statusCurrent positionBased on the latest supported relationship state
Peak shares1.36MHighest verified quarter-end share count
Quarters reported8Verified quarters with shares above zero
What happened?

Renaissance Technologies LLC first reported Globus Med Inc in Q3 2018. After an earlier exit, the position later appeared again in a verified filing. The reported position was increased and reduced across later filings. Renaissance Technologies LLC currently reports 196.92K shares. The latest verified filing showed: New position.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q2 2026
New position+196.92K shares · 196.92K shares reported
Filing context

Quarter-end price $79.01

Q4 2025
Sold the entire position−243.92K shares · No shares reported at quarter-end
Q1 2025
New position+176.92K shares · 176.92K shares reported
Filing context

Quarter-end price $73.20

Q1 2020
Bought 24.7% more+266.70K shares · 1.34M shares reported after the change
Filing context

Quarter-end price $42.53

Q3 2019
Sold 1.5% of the position−19.20K shares · 1.25M shares remained
Filing context

Quarter-end price $51.12

Q1 2019
Bought 11.2% more+137.40K shares · 1.36M shares reported after the change
Filing context

Quarter-end price $49.41

Portfolio importance

How important is Globus Med Inc in Renaissance Technologies LLC’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Current portfolio weight0.0%Q2 2026
Current rank#827of 3140 reported positions
Peak portfolio weight0.1%Q1 2019
Best historical rank#350Q1 2020
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$75.192026-09-22

Market context only; not an investor transaction price.

Latest filing quarter-end price$79.01Q2 2026

Derived from validated reported value and shares where supported.

Latest verified investor filingQ2 2026 · filed 2026-08-13
Open SEC filing ↗

Coverage is bounded to the institution’s top reported positions and material events rather than every security in each Form 13F. The filing reflects reportable U.S.-listed holdings, not Renaissance’s secret models, complete trading book, exact trade dates or execution prices.